Literature DB >> 9146728

Elevated levels of ERK2 in human breast carcinoma MCF-7 cells transfected with protein kinase C alpha.

A K Gupta1, S S Galoforo, C M Berns, A A Martinez, P M Corry, K L Guan, Y J Lee.   

Abstract

We investigated the effect of elevated levels of protein kinase C alpha (PKC alpha) on cell proliferation in human breast carcinoma cells (MCF-7). MCF-7 cells transfected with either the pSV2M(2)6 vector without the insert (MCF-7/Vector) or containing a full length cDNA encoding PKC alpha (MCF-7/PKC alpha) were compared. MCF-7/PKC alpha cells were found to have an increased proliferative rate with a doubling time of 15 h as compared to 42 h for MCF-7/Vector cells. Flow cytometry illustrated a greater percentage of MCF-7/PKC alpha cells in the S phase of the cell cycle. Western and Northern blot analyses demonstrated an increase in extracellular regulated protein kinase 2 (ERK2) gene expression in MCF-7/PKC alpha cells but no alteration of this gene expression in MCF-7/Vector cells. These results suggested that the elevated level of ERK2 which is also known as mitogen activated protein kinase is probably involved in the increase in MCF-7/PKC alpha cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9146728     DOI: 10.1111/j.1365-2184.1996.tb00979.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  5 in total

1.  Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway.

Authors:  Yuqi Wu; Xueyan Bai; Xiaoyang Li; Chang Zhu; Zachary P Wu
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

2.  Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells.

Authors:  Elizabeth C Martin; Steven Elliott; Lyndsay V Rhodes; James W Antoon; Claire Fewell; Yun Zhu; Jennifer L Driver; Mona Jodari-Karimi; Christopher W Taylor; Erik K Flemington; Barbara S Beckman; Bridgette M Collins-Burow; Matthew E Burow
Journal:  Mol Carcinog       Date:  2012-08-21       Impact factor: 4.784

3.  Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancer.

Authors:  J W Assender; J M W Gee; I Lewis; I O Ellis; J F R Robertson; R I Nicholson
Journal:  J Clin Pathol       Date:  2007-11       Impact factor: 3.411

4.  Isoform-specific and protein kinase C-mediated regulation of CTP:phosphoethanolamine cytidylyltransferase phosphorylation.

Authors:  Zvezdan Pavlovic; Lin Zhu; Leanne Pereira; Ratnesh Kumar Singh; Rosemary B Cornell; Marica Bakovic
Journal:  J Biol Chem       Date:  2014-02-10       Impact factor: 5.157

Review 5.  Berberine as a potential agent for breast cancer therapy.

Authors:  Xiao-Dan Zhong; Li-Juan Chen; Xin-Yang Xu; Yan-Jun Liu; Fan Tao; Ming-Hui Zhu; Chang-Yun Li; Dan Zhao; Guan-Jun Yang; Jiong Chen
Journal:  Front Oncol       Date:  2022-09-02       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.